Cargando…

Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers

INTRODUCTION: Advances in high-throughput technologies have generated diverse informative molecular markers for cancer outcome prediction. Long non-coding RNA (lncRNA) and DNA methylation as new classes of promising markers are emerging as key molecules in human cancers; however, the prognostic util...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Li, Fengji, Liang, Changning, Liu, Liangcai, Zhang, Yinghui, Li, Yu, Li, Shanguang, Chen, Jianghui, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659652/
https://www.ncbi.nlm.nih.gov/pubmed/26606135
http://dx.doi.org/10.1371/journal.pone.0142433
_version_ 1782402659352838144
author Xu, Li
Fengji, Liang
Changning, Liu
Liangcai, Zhang
Yinghui, Li
Yu, Li
Shanguang, Chen
Jianghui, Xiong
author_facet Xu, Li
Fengji, Liang
Changning, Liu
Liangcai, Zhang
Yinghui, Li
Yu, Li
Shanguang, Chen
Jianghui, Xiong
author_sort Xu, Li
collection PubMed
description INTRODUCTION: Advances in high-throughput technologies have generated diverse informative molecular markers for cancer outcome prediction. Long non-coding RNA (lncRNA) and DNA methylation as new classes of promising markers are emerging as key molecules in human cancers; however, the prognostic utility of such diverse molecular data remains to be explored. MATERIALS AND METHODS: We proposed a computational pipeline (IDFO) to predict patient survival by identifying prognosis-related biomarkers using multi-type molecular data (mRNA, microRNA, DNA methylation, and lncRNA) from 3198 samples of five cancer types. We assessed the predictive performance of both single molecular data and integrated multi-type molecular data in patient survival stratification, and compared their relative importance in each type of cancer, respectively. Survival analysis using multivariate Cox regression was performed to investigate the impact of the IDFO-identified markers and traditional variables on clinical outcome. RESULTS: Using the IDFO approach, we obtained good predictive performance of the molecular datasets (bootstrap accuracy: 0.71–0.97) in five cancer types. Impressively, lncRNA was identified as the best prognostic predictor in the validated cohorts of four cancer types, followed by DNA methylation, mRNA, and then microRNA. We found the incorporating of multi-type molecular data showed similar predictive power to single-type molecular data, but with the exception of the lncRNA + DNA methylation combinations in two cancers. Survival analysis of proportional hazard models confirmed a high robustness for lncRNA and DNA methylation as prognosis factors independent of traditional clinical variables. CONCLUSION: Our study provides insight into systematically understanding the prognostic performance of diverse molecular data in both single and aggregate patterns, which may have specific reference to subsequent related studies.
format Online
Article
Text
id pubmed-4659652
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46596522015-12-02 Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers Xu, Li Fengji, Liang Changning, Liu Liangcai, Zhang Yinghui, Li Yu, Li Shanguang, Chen Jianghui, Xiong PLoS One Research Article INTRODUCTION: Advances in high-throughput technologies have generated diverse informative molecular markers for cancer outcome prediction. Long non-coding RNA (lncRNA) and DNA methylation as new classes of promising markers are emerging as key molecules in human cancers; however, the prognostic utility of such diverse molecular data remains to be explored. MATERIALS AND METHODS: We proposed a computational pipeline (IDFO) to predict patient survival by identifying prognosis-related biomarkers using multi-type molecular data (mRNA, microRNA, DNA methylation, and lncRNA) from 3198 samples of five cancer types. We assessed the predictive performance of both single molecular data and integrated multi-type molecular data in patient survival stratification, and compared their relative importance in each type of cancer, respectively. Survival analysis using multivariate Cox regression was performed to investigate the impact of the IDFO-identified markers and traditional variables on clinical outcome. RESULTS: Using the IDFO approach, we obtained good predictive performance of the molecular datasets (bootstrap accuracy: 0.71–0.97) in five cancer types. Impressively, lncRNA was identified as the best prognostic predictor in the validated cohorts of four cancer types, followed by DNA methylation, mRNA, and then microRNA. We found the incorporating of multi-type molecular data showed similar predictive power to single-type molecular data, but with the exception of the lncRNA + DNA methylation combinations in two cancers. Survival analysis of proportional hazard models confirmed a high robustness for lncRNA and DNA methylation as prognosis factors independent of traditional clinical variables. CONCLUSION: Our study provides insight into systematically understanding the prognostic performance of diverse molecular data in both single and aggregate patterns, which may have specific reference to subsequent related studies. Public Library of Science 2015-11-25 /pmc/articles/PMC4659652/ /pubmed/26606135 http://dx.doi.org/10.1371/journal.pone.0142433 Text en © 2015 Xu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Xu, Li
Fengji, Liang
Changning, Liu
Liangcai, Zhang
Yinghui, Li
Yu, Li
Shanguang, Chen
Jianghui, Xiong
Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers
title Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers
title_full Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers
title_fullStr Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers
title_full_unstemmed Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers
title_short Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers
title_sort comparison of the prognostic utility of the diverse molecular data among lncrna, dna methylation, microrna, and mrna across five human cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659652/
https://www.ncbi.nlm.nih.gov/pubmed/26606135
http://dx.doi.org/10.1371/journal.pone.0142433
work_keys_str_mv AT xuli comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers
AT fengjiliang comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers
AT changningliu comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers
AT liangcaizhang comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers
AT yinghuili comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers
AT yuli comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers
AT shanguangchen comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers
AT jianghuixiong comparisonoftheprognosticutilityofthediversemoleculardataamonglncrnadnamethylationmicrornaandmrnaacrossfivehumancancers